en · de · es · pt
bpc-157-notes.peptides6088.com › Blog › Identity And Molecular Background — 2026 Update

Identity And Molecular Background — 2026 Update

By Editorial Desk · published 2026-06-07 · last reviewed 2026-07-22 · Blog

animal model is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Updated 2026-07-22. Numbers and descriptions here follow the published literature rather than marketing material.

Identity and Molecular Background

The sequence contains an unusually high proportion of proline and glycine, which limits regular secondary structure and contributes to solubility in aqueous media. The compound dissolves readily in water and in normal saline. Because it is a peptide, digestive enzymes are expected to break it down if it is swallowed, a consideration that influences the routes of administration used in animal experiments. Detailed conformational data remain limited, and published structural models are largely computational.

BPC 157 is a synthetic peptide built from fifteen amino acids. The letters stand for body protection compound, and the number is a laboratory code rather than a description of any biological feature. Its single-letter sequence is GEPPPGKPADDAGLV, which corresponds to a calculated mass near 1419.5 daltons. The material is produced by solid-phase peptide synthesis and is distributed as a lyophilized powder, not as a purified extract from a natural source.

Early work on this family of molecules examined fractions of human gastric juice, where a larger protein was reported to protect gastrointestinal tissue in animal models. BPC 157 was designed as a shorter, more stable fragment of that protein and then studied on its own. The peptide itself is not a normal dietary component and is not present in the human body in meaningful quantities. Descriptions of its origin therefore refer to the research lineage of a laboratory molecule rather than to an endogenous or nutritional substance.

Origin and Peptide Identity

Common synonyms in catalogs include pentadecapeptide BPC 157, BPC157, and the full sequence name. A CAS registry number in the 137525-51-0 range is frequently listed, though the assignment should be verified against the supplier certificate of analysis. The name itself is not a pharmacopoeial designation, and there is no standardized international nonproprietary name. Distinguishing genuine material from related fragments generally requires mass spectrometry, since several truncated sequences share similar chromatographic behavior.

BPC-157 is a synthetic pentadecapeptide whose sequence is commonly given as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is described in the literature as a fragment of a larger protein found in human gastric juice, referred to as body protection compound. The peptide was first characterized in the early 1990s by a research group in Zagreb, Croatia. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.

Supplied material is typically a lyophilized white to off-white powder. The peptide is freely soluble in water and in common aqueous buffers, which allows it to be handled as a stock solution. Because the sequence contains no cysteine, disulfide cross-linking is not a route of degradation. The absence of aromatic residues means ultraviolet absorbance at 280 nm is minimal, so quantification usually relies on peptide bond absorbance near 214 nm or on amino acid analysis.

Bpc-157 at a glance

PropertyValueNotes
Molecular weightAbout 1419.5 DaCalculated from the fifteen-residue sequence
Residue count15 amino acidsSingle-letter sequence GEPPPGKPADDAGLV
Compound classSynthetic peptideProduced by solid-phase synthesis
SynonymsBPC 157; pentadecapeptide BPC 157Naming varies across suppliers and papers
AppearanceWhite to off-white powderTypical form of the lyophilized material

Storage, Handling, and Analytical Verification

Purity is ordinarily reported as a percentage from reverse-phase high-performance liquid chromatography, where the area of the main peak is compared with the total peak area. Identity is confirmed by mass spectrometry, since the measured mass can be checked against the value calculated from the sequence. Some certificates also include amino acid analysis or sequence confirmation by tandem mass spectrometry. A single purity number does not describe the profile of related impurities, so the underlying chromatogram and spectrum usually carry more information than the headline figure.

Material of this kind is sold for laboratory research, and labels typically state that it is not intended for human or veterinary use. In many countries it is not an approved medicine, and sports antidoping rules place it among prohibited non-approved substances. Buyers commonly review a certificate of analysis, an independent test report, and the declared storage conditions. Batch-to-batch variation in purity and in counterion content is possible, and how much that variation affects experimental outcomes remains an open question.

Lyophilized peptide is normally kept at minus twenty degrees Celsius or colder, away from light and moisture. Powder held under those conditions is widely treated as stable for long periods, although published stability studies for this exact sequence are sparse and often come from suppliers rather than independent laboratories. Once dissolved, solutions are generally handled cold and used within a short window, because peptide bonds can hydrolyze over time. Repeated freeze-thaw cycles are usually avoided to limit losses, and exact shelf-life figures depend on the buffer and the concentration involved.

Related pages on this site

Research Literature and Evidence Gaps

Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.

Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.

Discovery and Research Background

Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.

Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.

BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.

Background and Chemical Identity

BPC-157 is a synthetic peptide built from fifteen amino acid residues. Its sequence comes from a larger protein fragment that researchers isolated from human gastric juice and described as a body protection compound. The fragment contains glycine, glutamic acid, five prolines, lysine, alanine, two aspartic acids, leucine, and valine. The number 157 in the name refers to the position of the stretch within the parent protein. Material used in laboratories is manufactured rather than extracted from stomach fluid.

The molecule carries 15 residues, a molar mass near 1419.5 g/mol, and the formula C62H98N16O22. Its structure features a proline-rich central region, a pair of adjacent aspartic acid residues, and no cysteine. The absence of cysteine means no disulfide bonds can form, which simplifies refolding and reconstitution. Suppliers usually ship the material as a freeze-dried powder that appears white to off-white. It dissolves readily in water and in saline solutions.

Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.

Further detail

CO2carbondioxide + 2H2Owater + photonslight energy → [CH2O]carbohydrate + O2oxygen + H2Owater This equation emphasizes that water is both a reactant in the light-dependent reaction and a product of the light-independent reaction, but canceling n water molecules from each side gives the net equation:

Genes for human growth hormone, known as growth hormone 1 (somatotropin; pituitary growth hormone) and growth hormone 2 (placental growth hormone; growth hormone variant), are localized in the q22-24 region of chromosome 17 and are closely related to human chorionic somatomammotropin (also known as placental lactogen) genes. GH, human chorionic somatomammotropin, and prolactin belong to a group of homologous hormones with growth-promoting and lactogenic activity.

Historically, the illicit drug trade in Colombia had strong connections to right-wing paramilitaries like the United Self-Defenders of Colombia (AUC) and leftist guerilla groups like the Revolutionary Armed Forces of Colombia (FARC), thus US anti-drug efforts in the country overlapped with support for counterinsurgency efforts. In the late 1960s, when drug smuggling to the US from Mexico rose to a major scale, the two governments cooperated in the launch of the Mexican drug war; the market disruption gave Colombian traffickers an opportunity to fill US demand for cannabis. Until the 1970s, Colombia "had played no major role in the production and circulation of illegal drugs in the hemisphere". After a military coup in Chile in 1973 and the spread of political repression through the Southern Cone countries disrupted cocaine smuggling from Peru and Bolivia, Colombia stepped in to fill the demand for cocaine. Pressed by the US, the Colombian government, under president Misael Pastrana (1970–1974), worked with the newly formed DEA to establish the future path for the country's war on drugs. During the 1970s, the "marijuana boom" dominated Colombia's drug trade, peaking mid-decade. That soon gave way to cocaine and the rise of the infamous Medellin and Cali Cartels that grew through the 1980s and early 1990s to dominate the global cocaine market. By the end of the century, the brutal anti-drug war left the security situation in Colombia in critical condition.

==== Central nervous system and appetite regulation ==== GLP-1 receptor activation stimulates satiety, thus reducing food intake, promoting the development of a negative energy balance, and decreasing body weight over time, making GLP-1 agonists a treatment option for obesity. In the hypothalamus, this is achieved by stimulating anorexigenic (satiety-inducing) POMC and CART neurons while simultaneously inhibiting orexigenic (appetite-inducing) AgRP and NPY neurons. GLP-1 agonists also counteract obesity-induced leptin resistance. They do this by downregulating inhibitory proteins like SOCS3 and PTP1B, which restores the brain's JAK/STAT signaling cascade and re-establishes sensitivity to leptin.

== Role in B and T Cell Production and Homeostasis == Reticular cells play a central role in the development and homeostasis of both B and T lymphocytes. Within the lymph node, fibroblastic reticular cells form a 3D network that acts as both a structural outline and communication network for immune signaling. Immune signaling is crucial to survival of the human body. These specific structures allow T cells to migrate efficiently through the lymph node, scanning for antigens presented by dendritic cells while doing so. In the T-cell zones of lymph nodes as described above, reticular cells secrete interleukin-7 (IL-7). This is a cytokine critical for both the maintenance and survival of T cells. Link et al. (2007) demonstrated that when lymph nodes or reticular cell-derived IL-7 are disrupted, T cell survival decreases significantly. Additionally, these same reticular cells release CCL19, a chemokine that regulates T cell movement and also helps maintain overall T-cell well-being. The balance between these two signaling molecules ensures that T cells remain functional and ready to respond rapidly to presented antigens. Beyond just T cells, reticular cells are equally essential for B cell homeostasis. According to Cremasco et al. (2014), reticular cells produce BAFF (B-cell activating factor), a survival signal that helps to sustain B cell populations within lymphoid follicles. When reticular cells were experimentally removed, it was shown that B cell organization collapses.

Sources: en.wikipedia.org

Background from the literature

== Genetics == Mutations in the COL11A1, COL11A2 and COL2A1 genes cause Stickler syndrome. These genes are involved in the production of type II and type XI collagen. Collagens are complex molecules that provide structure and strength to connective tissue (the tissue that supports the body's joints and organs). Mutations in any of these genes disrupt the production, processing, or assembly of type II or type XI collagen. Defective collagen molecules or reduced amounts of collagen affect the development of bones and other connective tissues, leading to the characteristic features of Stickler syndrome. Other, as yet unknown, genes may also cause Stickler syndrome because not all individuals with the condition have mutations in one of the three identified genes.

GameSpy hailed Natural Selection as "possibly the most ambitious user-made modification ever brought to fruition. This multiplayer-only mod somehow manages to transform the aging Half-Life into a seemingly brand-new, atmospheric, and surprisingly deep action-strategy game, pitting hive-minded aliens against resourceful space marines," and "Natural Selection's innovations are too numerous to list, but the marine's "commander" mode deserves special mention. Playing as the marine commander, you can order and re-supply other marines in an RTS-style, top-down perspective." FiringSquad : "The way all these details boil down in gameplay is simply amazing, and occasionally fascinating to just watch unfold," and "is probably one of the most creative and well thought out shooters we’ve played in a very long time."

=== Mechanism of liver injury === The cause of the mild, transient serum enzyme elevations during imipenem-cilastatin therapy is not known. The cholestatic hepatitis attributed to imipenem-cilastatin and the carbapenems is probably immunoallergic and resembles the rare, clinically apparent liver injury that has been linked to penicillins and cephalosporins.

=== Chinese Civil War: relations with Nationalists and Communists === Liu Wenhui's relationship with the Nationalist government continued to be one of grudging acceptance due to the fact that Xikang was too far from the central government in Nanjing to reliably influence or coerce. It is also believed by historian Kim Hee-shin that Chiang tolerated Liu's presence in Xikang to prevent the Sichuan warlord Liu Xiang from becoming too powerful. In 1936 Liu Wenhui's ties with Chiang soured even further due to his independent policy, but Chiang was not powerful enough to do anything meaningful against him at the time. Liu's relationship had a cooperative relationship with Sichuan governor Zhang Qun, the leader of the KMT's Political Science Clique. Both men being Sichuan natives, Liu was able to appeal to these provincial ties to enlist Zhang's support in negotiations with Chiang. Zhang, for his part, supported Liu as a counterweight to other Sichuanese warlords. In 1939, fighting broke out in Garzê between the officers of the deceased Panchen Lama and Liu Wenhui's army. Liu spread rumors about northern Kham potentially being granted to the Panchen Lama's office by the Kuomintang, and drove out the Lama's men. Although the Panchen Lama's forces were normally KMT-aligned, the central government remained on good terms with Liu Wenhui, who by now had taken advantage of the war against Japan to acquire more funding for Xikang. In January 1947, an anti-Liu uprising led by Zhu Shizheng (朱世正) captured the towns of Lushan and Tianqian and attempted to take Ya'an.

Sources: en.wikipedia.org

Frequently asked questions

Is BPC 157 a natural substance?

It is a synthetic peptide. Its design was inspired by a fragment of a protein found in human gastric juice, but the fifteen-amino-acid molecule itself is made in a laboratory and is not a normal component of food or of human tissue in appreciable amounts.

What does the number in the name refer to?

The number is an internal laboratory designation from the research group that first described the fragment. It does not encode a molecular weight, a receptor target, or a measured biological effect, and it carries no meaning outside the naming history of the compound.

How large is the molecule?

It contains fifteen amino acid residues and has a calculated mass of roughly 1419.5 daltons. That places it in the short-peptide range, well below the size of small proteins, which affects how it is synthesized, purified, and analyzed.

What is BPC-157 chemically?

It is a synthetic peptide built from fifteen amino acids, with a mass of roughly 1419 daltons. The sequence is reported to match a fragment of a protein present in human gastric juice. It is not a naturally circulating hormone.

Network